Mesoridazine
Back to searchMolecule Structure
Scientific Name
Mesoridazine
Description of the Drug
Mesoridazine is a phenothiazine antipsychotic used to treat schizophrenia, organic brain disorders, alcoholism, and psychoneuroses.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00933
http://www.drugbank.ca/drugs/DB00933
Brand Name(s)
Lidanar
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
| Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL19735 | |
| PharmGKB | PA450386 | |
| Human Metabolome Database | HMDB0015068 | |
| DrugBank | DB00933 | |
| PubChem: Thomson Pharma | 14927472 | |
| PubChem | 4078 | |
| NMRShiftDB | 70092989 | |
| LINCS | LSM-1329 | |
| Nikkaji | J8.016K | |
| BindingDB | 50131440 | |
| EPA CompTox Dashboard | DTXSID3023265 | |
| DrugCentral | 1712 | |
| Brenda | 225660 | |
| ChemicalBook | CB0875422 | CB0157447 |
| Guide to Pharmacology | 7227 | |
| rxnorm | MESORIDAZINE | MESORIDAZINE BESYLATE |
| KEGG Ligand | C07143 | |
| ChEBI | 6780 |
